MeiraGTx Holdings: Behind The Recent Rally

Group 1 - The biotech forum has seen significant discussions around profitable buy-write or covered call strategies on selected biotech stocks in recent months [1] - MeiraGTx Holdings plc has experienced a stock price increase of over 40% following the release of Parkinson's disease data on October 15, 2024, which is expected to facilitate a pivotal trial [2] - The investing group, The Biotech Forum, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat for trade discussions and weekly market commentary [2]